Khondrion
About Khondrion
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Government Grant and Private Investment T: - FT: Government Grant and Private Investment |
A: 5400000 MR: - FA: up to €5 Million FAN: 5400000 |
D: 2025-05-06 FD: 2025-05-06 |
2 investors |
Growth Metrics
Team & Leadership
Jan Smeitink
Chief Executive Officer
Herma Renkema
Chief Scientific Officer
Jasper Levink
Chief Financial Business Officer
Doug Turnbull
Professor of Neurology, Newcastle University
Marni Falk
Executive Director, CHOP Mitochondrial Medicine Frontier Program and Professor, Division of Human Genetics, Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, USA
Michelangelo Mancuso
Professor of Neurology, Department of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, Italy; Chair, Neurogenetics and Rare Diseases Panel - Italian Society of Neurology; Chair, Neurogenetics Panel of the European Academy of Neurology
Recent News
Khondrion Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- khondrion.com
- Industries
- Biopharmaceutical
- Company Size
- ~220 employees (est.)
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro